Antonietta Pecoriello
6 Papers
6 Citations
Antonietta Pecoriello is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients.
Giulia Rastrelli,Vincenza Di Stasi,Francesco Inglese,Massimiliano Beccaria,Martina Garuti,Domenica Di Costanzo,Fabio Spreafico,Graziana Francesca Greco,Giulia Cervi,Antonietta Pecoriello,A. Magini,Tommaso Todisco,Sarah Cipriani,Elisa Maseroli,Giovanni Corona,Andrea Salonia,Andrea Lenzi,Mario Maggi,Giuseppe De Donno,Linda Vignozzi +19 more
TL;DR: The pandemic of new severe acute respiratory syndrome (Sars) due to coronavirus (CoV) 2 (SARS‐CoV‐2) has stressed the importance of effective diagnostic and prognostic biomarkers of clinical worsening and mortality.
349
Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience
Massimo Franchini,Claudia Glingani,G. De Donno,Giuseppe Lucchini,Massimiliano Beccaria,Massimo Amato,Gian Paolo Castelli,Leonardo Bianciardi,Marco Pagani,Marco Ghirardini,Giuseppe Puma,Barbara Presciuttini,Maria Teresa Costantino,M Frigato,Verena Crosato,G. Tiecco,Alice Mulè,Dorothea Angela Papalia,Francesco Inglese,Fabio Spreafico,Martina Garuti,Antonietta Pecoriello,Giulia Cervi,Graziana Francesca Greco,V Galavotti,Tiziana Santini,Angela Berselli,Carlos Montalto,Riccardo Bertoletti,Simona Aurelia Bellometti,Enrico Capuzzo,Dario Benazzi,G. Grisolia,Fabio Pajola,R. Stradoni,Matteo Zani,Adriano Verzola,Codeluppi,Silvia Vesentini,Elisa Bellocchio,Marco Candini,G. Ambrosi,F. Carandina,Cleante Scarduelli,Albino Reggiani,Salvatore Casari,On Behalf Of Convalescent Plasma Study Group +46 more
TL;DR: In this real-life experience, the first in the western world, early administration of high-titer CCP was a safe and effective treatment for hospitalized COVID-19 patients.
Pulmonary embolism in patients with severe COVID-19 treated with intermediate- to full-dose enoxaparin: A retrospective study.
Cleante Scarduelli,Francesco Inglese,Massimiliano Beccaria,Fabio Speafico,Martina Garuti,Antonietta Pecoriello,Giulia Cervi,Graziana Francesca Greco,Sara Scarduelli,Giuseppe Lucchini,Giuseppe De Donno,Claudio Borghi +11 more
- 16 Mar 2021
TL;DR: In this paper, the authors reported the prevalence of pulmonary embolisms in patients with COVID-19 and severe respiratory failure (SRF) treated with intermediate-to full-dose enoxaparin.
Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients
Giulia Rastrelli,Vincenza Di Stasi,Francesco Inglese,Massimiliano Beccaria,Martina Garuti,Domenica Di Costanzo,Fabio Spreafico,Graziana Francesca Greco,Giulia Cervi,Antonietta Pecoriello,Angela Magini,Tommaso Todisco,Sarah Cipriani,Elisa Maseroli,Giovanni Corona,Andrea Salonia,Andrea Lenzi,Mario Maggi,Giuseppe De Donno,Linda Vignozzi +19 more
TL;DR: Low testosterone levels predict adverse clinical outcomes in SARS-CoV-2 pneumonia patients.
Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study.
V. Di Stasi,Giulia Rastrelli,Francesco Inglese,Massimiliano Beccaria,Martina Garuti,D. Di Costanzo,Fabio Spreafico,Giulia Cervi,Graziana Francesca Greco,Antonietta Pecoriello,Tommaso Todisco,Sarah Cipriani,Elisa Maseroli,Irene Scavello,Claudia Glingani,Massimo Franchini,Mario Maggi,G. De Donno,Linda Vignozzi +18 more
TL;DR: In this paper, the association between testosterone (T) levels and biochemical markers in a cohort of female patients admitted for SARS-CoV-2 infection in a respiratory intensive care unit (RICU) was assessed.